These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
118 related items for PubMed ID: 1942931
1. [Cardiomyopathy after osteosarcoma treatment: a contribution to the cardiotoxicity of adriamycin]. Geidel S, Garn M, Grävinghoff L, Hausdorf G, Morf G, Bielack S, Knop J, Winkler K. Klin Padiatr; 1991; 203(4):257-61. PubMed ID: 1942931 [Abstract] [Full Text] [Related]
2. Long-term follow-up of patients with doxorubicin-induced cardiac toxicity after chemotherapy for osteosarcoma. Longhi A, Ferrari S, Bacci G, Specchia S. Anticancer Drugs; 2007 Jul; 18(6):737-44. PubMed ID: 17762406 [Abstract] [Full Text] [Related]
3. Subclinical late cardiomyopathy after doxorubicin therapy for lymphoma in adults. Hequet O, Le QH, Moullet I, Pauli E, Salles G, Espinouse D, Dumontet C, Thieblemont C, Arnaud P, Antal D, Bouafia F, Coiffier B. J Clin Oncol; 2004 May 15; 22(10):1864-71. PubMed ID: 15143078 [Abstract] [Full Text] [Related]
4. Prospective longitudinal evaluation of doxorubicin-induced cardiomyopathy in sarcoma patients: a report of the late effects surveillance system (LESS). Paulides M, Kremers A, Stöhr W, Bielack S, Jürgens H, Treuner J, Beck JD, Langer T, German Late Effects Working Group in the Society of Pediatric Oncology and Haematology (GPOH). Pediatr Blood Cancer; 2006 Apr 15; 46(4):489-95. PubMed ID: 16333817 [Abstract] [Full Text] [Related]
5. Limited cardiotoxicity after extensive thoracic surgery and intraoperative hyperthermic intrathoracic chemotherapy with doxorubicin and cisplatin. de Bree E, van Ruth S, Schotborgh CE, Baas P, Zoetmulder FA. Ann Surg Oncol; 2007 Oct 15; 14(10):3019-26. PubMed ID: 17638057 [Abstract] [Full Text] [Related]
6. Cardiac troponin I: is it a marker to detect cardiotoxicity in children treated with doxorubicin? Köseoğlu V, Berberoğlu S, Karademir S, Kismet E, Yurttutan N, Demirkaya E, Sungur M, Alehan D. Turk J Pediatr; 2005 Oct 15; 47(1):17-22. PubMed ID: 15884624 [Abstract] [Full Text] [Related]
7. Phase II clinical and pharmacological study of pirarubicin in combination with 5-fluorouracil and cyclophosphamide in metastatic breast cancer. Dhingra K, Frye D, Newman RA, Walters R, Theriault R, Fraschini G, Smith T, Buzdar A, Hortobagyi GN. Clin Cancer Res; 1995 Jul 15; 1(7):691-7. PubMed ID: 9816034 [Abstract] [Full Text] [Related]
8. [Echocardiography with angiotensin administration in the diagnosis of adriamycin-induced cardiomyopathy]. Göldel N, Autenrieth G, Werdan K, Knesewitsch P, Wilmanns W. Z Kardiol; 1989 May 15; 78(5):320-7. PubMed ID: 2735093 [Abstract] [Full Text] [Related]
9. Dose intensity of chemotherapy for osteosarcoma and outcome in the Cooperative Osteosarcoma Study Group (COSS) trials. Eselgrim M, Grunert H, Kühne T, Zoubek A, Kevric M, Bürger H, Jürgens H, Mayer-Steinacker R, Gosheger G, Bielack SS. Pediatr Blood Cancer; 2006 Jul 15; 47(1):42-50. PubMed ID: 16206218 [Abstract] [Full Text] [Related]
10. [Neoadjuvant chemotherapy of osteosarcoma. Results of the cooperative studies COSS-80 and COSS-82 after 7 and 5 years]. Bielack S, Beck J, Delling G, Gerein V, Grümayer R, Hiddemann W, Jobke A, Jürgens H, Kornhuber G, Kotz R. Klin Padiatr; 1989 Jul 15; 201(4):275-84. PubMed ID: 2674532 [Abstract] [Full Text] [Related]
11. Can cure in patients with osteosarcoma be achieved exclusively with chemotherapy and abrogation of surgery? Jaffe N, Carrasco H, Raymond K, Ayala A, Eftekhari F. Cancer; 2002 Nov 15; 95(10):2202-10. PubMed ID: 12412175 [Abstract] [Full Text] [Related]
12. [Evaluation of adjuvant chemotherapy of osteosarcoma with special reference to adriamycin (final report)]. Maeyama I, Furuse K, Yamawaki S, Abe M, Tateishi A, Takeyama S, Furuya K, Fukuma H, Takeuchi S, Shinohara N. Gan To Kagaku Ryoho; 1988 Dec 15; 15(12):3245-51. PubMed ID: 3196042 [Abstract] [Full Text] [Related]
13. [Congestive cardiomyopathy after doxorubicin (adriamycin)author's transl)]. Kaduk B, Seiler G. Dtsch Med Wochenschr; 1977 Dec 09; 102(49):1813-7. PubMed ID: 271071 [Abstract] [Full Text] [Related]
14. Comparison of doxorubicin cardiotoxicity in pediatric sarcoma patients when given with dexrazoxane versus as continuous infusion. Huh WW, Jaffe N, Durand JB, Munsell MF, Herzog CE. Pediatr Hematol Oncol; 2010 Oct 09; 27(7):546-57. PubMed ID: 20795769 [Abstract] [Full Text] [Related]
15. Neoadjuvant chemotherapy with high-dose Ifosfamide, high-dose methotrexate, cisplatin, and doxorubicin for patients with localized osteosarcoma of the extremity: a joint study by the Italian and Scandinavian Sarcoma Groups. Ferrari S, Smeland S, Mercuri M, Bertoni F, Longhi A, Ruggieri P, Alvegard TA, Picci P, Capanna R, Bernini G, Müller C, Tienghi A, Wiebe T, Comandone A, Böhling T, Del Prever AB, Brosjö O, Bacci G, Saeter G, Italian and Scandinavian Sarcoma Groups. J Clin Oncol; 2005 Dec 01; 23(34):8845-52. PubMed ID: 16246977 [Abstract] [Full Text] [Related]
16. [Is the use of adriamycin (doxorubicin) limited by its cardiotoxicity?]. Reinhardt D, Hofmann V, Martz G. Schweiz Med Wochenschr; 1985 Apr 20; 115(16):557-61. PubMed ID: 4001904 [Abstract] [Full Text] [Related]
17. Adriamycin cardiotoxicity: a survey of 1273 patients. Praga C, Beretta G, Vigo PL, Lenaz GR, Pollini C, Bonadonna G, Canetta R, Castellani R, Villa E, Gallagher CG, von Melchner H, Hayat M, Ribaud P, De Wasch G, Mattsson W, Heinz R, Waldner R, Kolaric K, Buehner R, Ten Bokkel-Huyninck W, Perevodchikova NI, Manziuk LA, Senn HJ, Mayr AC. Cancer Treat Rep; 1979 May 20; 63(5):827-34. PubMed ID: 455324 [Abstract] [Full Text] [Related]
18. Cardiac function and cardiopulmonary performance in patients after treatment for non-Hodgkin's lymphoma. Elbl L, Vasova I, Tomaskova I, Jedlicka F, Navratil M, Pospisil Z, Vorlicek J. Neoplasma; 2006 May 20; 53(2):174-81. PubMed ID: 16575475 [Abstract] [Full Text] [Related]
19. [Drug-induced myocardial disease--adriamycin cardiotoxicity]. Wakasugi S. Nihon Rinsho; 2000 Jan 20; 58(1):204-11. PubMed ID: 10885315 [Abstract] [Full Text] [Related]